Early pathologic amyloid induces hypersynchrony of BOLD resting-state networks in transgenic mice and provides an early therapeutic window before amyloid.

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

Fig. 2. The expression of pKr-2 in the substantia nigra (SN) of patients with Parkinson's disease (PD). (A, B) Western blot analysis for pKr-1-2 and pKr-2,
Fig. 1 Anti-inflammatory drug treatment reduces the number of reactive microglia in the hippocampus of APPV717I mice. APPV717I transgenic mice (10 months.
Balpreet Matharu, Nick Spencer, Franklyn Howe, Brian Austen 
Age-related toxicity of amyloid-beta associated with increased pERK and pCREB in primary hippocampal neurons: reversal by blueberry extract  Gregory J.
Jiang Wu, Bihua Bie, Hui Yang, Jijun J. Xu, David L
Volume 1, Issue 3, Pages (November 2015)
NPT088 reduces both amyloid-β and tau pathologies in transgenic mice
Beneficial synergistic effects of microdose lithium with pyrroloquinoline quinone in an Alzheimer's disease mouse model  Lei Zhao, Neng Gong, Meng Liu,
Brain Trauma Induces Massive Hippocampal Neuron Death Linked to a Surge in β- Amyloid Levels in Mice Overexpressing Mutant Amyloid Precursor Protein  Douglas.
Biphasic Alteration of the Inhibitory Synapse Scaffold Protein Gephyrin in Early and Late Stages of an Alzheimer Disease Model  Eva Kiss, Karin Gorgas,
Volume 63, Issue 3, Pages (August 2009)
Volume 18, Issue 3, Pages (September 2013)
Volume 97, Issue 6, Pages e5 (March 2018)
Low back pain and disc degeneration are decreased following chronic toll-like receptor 4 inhibition in a mouse model  Emerson Krock, Magali Millecamps,
Volume 7, Issue 3, Pages (May 2014)
Presynaptic Self-Depression at Developing Neocortical Synapses
Microglia Current Biology
Chemogenetic Interrogation of a Brain-wide Fear Memory Network in Mice
Frontal Cortex and the Discovery of Abstract Action Rules
Molecular Therapy - Nucleic Acids
Volume 63, Issue 3, Pages (August 2009)
Volume 24, Issue 17, Pages (September 2014)
Tara L. Spires-Jones, Bradley T. Hyman  Neuron 
by Soyon Hong, Victoria F. Beja-Glasser, Bianca M
Volume 47, Issue 6, Pages (September 2005)
Volume 15, Issue 9, Pages (May 2016)
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
ApoE4 Accelerates Early Seeding of Amyloid Pathology
Volume 39, Issue 3, Pages (July 2003)
Neural Correlates of Visual Working Memory
Volume 78, Issue 4, Pages (May 2013)
Volume 134, Issue 4, Pages (April 2008)
Volume 5, Issue 5, Pages (November 2015)
Volume 1, Issue 6, Pages (June 2012)
FK506 Controls CD40L-Induced Systemic Autoimmunity in Mice
Rosanna P. Sammons, Claudia Clopath, Samuel J. Barnes  Cell Reports 
Volume 85, Issue 3, Pages (February 2015)
Volume 113, Issue 10, Pages (November 2017)
Volume 88, Issue 3, Pages (November 2015)
Volume 7, Issue 10, Pages (October 1997)
Volume 71, Issue 5, Pages (September 2011)
In Vivo Direct Reprogramming of Reactive Glial Cells into Functional Neurons after Brain Injury and in an Alzheimer’s Disease Model  Ziyuan Guo, Lei Zhang,
A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis  Caitlin S. Latimer, Carol A. Shively,
Experience-Dependent Equilibration of AMPAR-Mediated Synaptic Transmission during the Critical Period  Kyung-Seok Han, Samuel F. Cooke, Weifeng Xu  Cell.
Volume 28, Issue 3, Pages (December 2000)
Volume 60, Issue 2, Pages (October 2008)
Volume 64, Issue 5, Pages (December 2009)
Volume 23, Issue 4, Pages (April 2015)
Volume 17, Issue 5, Pages (May 2009)
Bo Li, Ran-Sook Woo, Lin Mei, Roberto Malinow  Neuron 
A. Sophocleous, A.E. Börjesson, D.M. Salter, S.H. Ralston 
Pathological Tau Disrupts Ongoing Network Activity
Neuronal ATM level is reduced in mouse models of AD
Functional MRI Evidence for LTP-Induced Neural Network Reorganization
CDT2-controlled cell cycle reentry regulates the pathogenesis of Alzheimer's disease  Fang Huang, Minghui Wang, Rong Liu, Jian-Zhi Wang, Eric Schadt, Vahram.
Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease 
Volume 71, Issue 5, Pages (September 2011)
Doublecortin expression in CD8+ T-cells and microglia at sites of amyloid-β plaques: A potential role in shaping plaque pathology?  Michael S. Unger,
A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42  Kristel Sleegers,
Inflammation is associated with increased basal-cell plasticity in the Nkx3.1 mutant prostate. Inflammation is associated with increased basal-cell plasticity.
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study  Osama Sabri, Marwan N. Sabbagh, John Seibyl, Henryk Barthel,
Volume 49, Issue 4, Pages (February 2006)
Cerebral hypoperfusion is not associated with an increase in amyloid β pathology in middle-aged or elderly people  Oskar Hansson, Sebastian Palmqvist,
Volume 20, Issue 3, Pages (March 1998)
Suzanne E. Schindler, Julia D. Gray, Brian A
A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis  Caitlin S. Latimer, Carol A. Shively,
Doublecortin expression in CD8+ T-cells and microglia at sites of amyloid-β plaques: A potential role in shaping plaque pathology?  Michael S. Unger,
Volume 87, Issue 6, Pages (December 1996)
Fig. 2. SUS reduces Aβ plaques in an AD mouse model.
Presentation transcript:

Early pathologic amyloid induces hypersynchrony of BOLD resting-state networks in transgenic mice and provides an early therapeutic window before amyloid plaque deposition  Disha Shah, Jelle Praet, Amira Latif Hernandez, Corinna Höfling, Cynthia Anckaerts, Frédérique Bard, Markus Morawski, Jan R. Detrez, Els Prinsen, Alessandro Villa, Winnok H. De Vos, Adriana Maggi, Rudi D'Hooge, Detlef Balschun, Steffen Rossner, Marleen Verhoye, Annemie Van der Linden  Alzheimer's & Dementia: The Journal of the Alzheimer's Association  Volume 12, Issue 9, Pages 964-976 (September 2016) DOI: 10.1016/j.jalz.2016.03.010 Copyright © 2016 The Alzheimer's Association Terms and Conditions

Fig. 1 BOLD FC matrices in the TG2576 mouse model at pre-plaque and post-plaque stages. This figure shows mean FC strength matrices of wild type (WT) (lower half) versus TG2576 (upper half) mice. The BOLD FC matrices show functional correlation strengths between pairs of brain regions at 3, 5, and 8 (pre-plaque stages) and 14 and 18 (post-plaque stages) months. The color scale represents the strength of the functional correlation. The different brain ROIs and their abbreviations are listed in Supplementary Table 1. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2016 12, 964-976DOI: (10.1016/j.jalz.2016.03.010) Copyright © 2016 The Alzheimer's Association Terms and Conditions

Fig. 2 The earliest signs of hypersynchronous BOLD FC are observed in the hippocampus network. (A) Mean BOLD FC strength is shown per brain network for wild-type versus TG2576 mice at 3 and 5 months. (B) Mean BOLD FC strength of the hippocampus is shown for all age groups in wild-type and TG2576 mice. *P value <.05, **P value <.01, ***P value <.001. All values are presented as mean ± standard error. (C) Three axial slices of the mean statistical hippocampus zFC maps for 5-month-old wild-type and TG2576 mice are shown as an overlay on an anatomic T2-weighted MRI image. The positioning of the slices is shown on a coronal brain image. The zFC maps are additionally shown on a 3D rendering. The color scale represents the T value, that is, the strength of functional correlation with the right hippocampus. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2016 12, 964-976DOI: (10.1016/j.jalz.2016.03.010) Copyright © 2016 The Alzheimer's Association Terms and Conditions

Fig. 3 Inflammation, Aβ load, and electrophysiology in the hippocampus of TG2576 mice at 5 months. (A) Mean % area GFAP and Iba1 for wild type and TG2576 mice. One representative image of a wild type and TG2576 animal is shown for each staining (scale bar indicates 100 μm). (B) Mean mRNA expression (fold wild type) of qPCR markers of inflammation for wild-type and TG2576 mice. (C) Mean % area thioflavin-S (left y-axis) and mean-soluble Aβ (pg/mL brain homogenate) (right y-axis) for wild-type and TG2576 mice. (D) Input/output (I/O) curve represented as mean field EPSP (V/s) for wild-type and TG2576 mice. (E) Paired pulse facilitation (PPF) is shown as the mean PPF ratio at different inter stimulus intervals (ISI) for wild-type and TG2576 mice. (F) Long-term potentiation (LTP) represented as the mean field EPSP slope (% of baseline) for wild type and TG2576 mice. *P value <.05. All values are presented as mean ± standard error. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2016 12, 964-976DOI: (10.1016/j.jalz.2016.03.010) Copyright © 2016 The Alzheimer's Association Terms and Conditions

Fig. 4 Hypersynchronous BOLD FC in the PDAPP mouse model versus wild types at a pre-plaque stage. (A) Mean FC matrices of the wild-type (WT) (lower half) and PDAPP (upper half) mice show functional correlation strengths between pairs of brain regions. The color scale represents the strength of the functional correlation. The different brain ROIs and their abbreviations are listed in Supplementary Table 1. (B) Mean BOLD FC strength per brain network for wild-type and PDAPP mice. (C) Mean BOLD FC of the frontal network at 3, 5, and 7 months of age in wild-type and PDAPP mice. (D) Mean % area thioflavin-S (left y-axis) and mean-soluble Aβ (pg/mL brain homogenate) (right y-axis) in the frontal cortex for wild-type and PDAPP mice. *P value <.05, **P value <.01. All values are presented as mean ± standard error. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2016 12, 964-976DOI: (10.1016/j.jalz.2016.03.010) Copyright © 2016 The Alzheimer's Association Terms and Conditions

Fig. 5 Early treatment with 3D6 restores FC abnormalities in TG2576 mice at a pre-plaque stage. (A) Mean FC strength matrices of wild-type (WT) (lower half) versus TG2576 (upper half) mice after treatment with PBS or 3D6. The FC matrices show functional correlation strengths between pairs of brain regions. The color scale represents the strength of the functional correlation. The different brain ROIs and their abbreviations are listed in Supplementary Table 1. (B) Three axial slices of the mean statistical hippocampus zFC maps are shown for PBS-treated wild-type and TG2576 mice and 3D6-treated wild-type and TG2576 mice at 5 months. ZFC maps are shown as an overlay on an anatomic T2-weighted MRI image. The positioning of the slices is shown on a coronal brain image. The zFC maps are additionally shown on a 3D rendering. The color scale represents the T value, that is, the strength of functional correlation with the right hippocampus. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2016 12, 964-976DOI: (10.1016/j.jalz.2016.03.010) Copyright © 2016 The Alzheimer's Association Terms and Conditions

Fig. 6 Treatment with 3D6 prevents FC and synaptic abnormalities in the hippocampus network in 5 months old TG2576 mice. (A) Mean BOLD FC strength in the hippocampus network for PBS-treated wild-type and TG2576 mice, and 3D6-treated wild-type and TG2576 mice at 3, 5, 7, 8, and 10 months of age. Treatment started at 3 months of age and was concluded at 5 months of age. (B) Mean PPF ratio at different inter stimulus intervals (ISI) for PBS-treated wild type and TG2576 mice, and 3D6-treated wild type and TG2576 mice at 5 months. (C) Mean density VGLUT1 (left y-axis), mean density GAD65-67 (left y-axis), and mean VGLUT1/GAD65-67 ratio (right y-axis) for PBS-treated wild types and TG2576 mice, and 3D6-treated wild types and TG2576 mice at the age of 5 months. One representative image is shown for each group (VGLUT1 red, GAD65/67 green, scale bar indicates 8 μm). The upper panel shows immunofluorescent images, the lower panel shows thresholded images. (D) Mean glutamate/GABA ratio for PBS-treated wild types and TG2576 mice, and 3D6-treated wild-types and TG2576 mice at 5 months of age. (E) Mean density synapsin and synaptobrevin for PBS-treated wild types and TG2576 mice, and 3D6-treated wild types and TG2576 mice at the age of 5 months. One representative image is shown for each group (synapsin red, synaptobrevin green, scale bar indicates 8 μm). The upper panel shows immunofluorescent images, the lower panel shows thresholded images. *P value <.05, **P value <.01, *** P value <.001. All values are presented as mean ± standard error. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2016 12, 964-976DOI: (10.1016/j.jalz.2016.03.010) Copyright © 2016 The Alzheimer's Association Terms and Conditions

Supplementary Fig. 1 Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2016 12, 964-976DOI: (10.1016/j.jalz.2016.03.010) Copyright © 2016 The Alzheimer's Association Terms and Conditions

Supplementary Fig. 2 Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2016 12, 964-976DOI: (10.1016/j.jalz.2016.03.010) Copyright © 2016 The Alzheimer's Association Terms and Conditions

Supplementary Fig. 3 Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2016 12, 964-976DOI: (10.1016/j.jalz.2016.03.010) Copyright © 2016 The Alzheimer's Association Terms and Conditions